• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Agilent (A) Stock Looks Overvalued Following Its 66% Three Year Run

    Simply Wall St·11/05/2026 06:32:55
    Listen to the news

    Agilent Technologies has delivered a solid multi year share price run, and the latest product launches and acquisitions now raise a sharper question about whether the current valuation is fully supported by the cash flows behind the stock.

    • Over the past 3 years, Agilent Technologies has returned 65.6%, which puts real weight on whether that share price performance is matched by the cash the business can generate.
    • The completed purchase of digital pathology software provider Proscia, together with new lab instruments and partnerships, can influence expectations for future cash generation and the timing of those inflows, especially as more revenue may come from software and services.
    • If you'd rather focus on earnings, this one's for you. See what Agilent Technologies's 34.7x P/E says about the price.

    The issue now is whether Agilent Technologies' current share price is appropriately aligned with its intrinsic value based on the cash flows investors expect it to produce.

    To see how this same cash flow question applies across a wider set of opportunities, compare Agilent Technologies with 35 high quality undervalued stocks.

    Has Agilent Technologies Run Too Far on Cash Flow?

    The Discounted Cash Flow (DCF) approach here focuses on the cash Agilent Technologies can return to shareholders over time, adjusted back to today in $ terms. The latest twelve month free cash flow sits around $1.21b, and the 2 Stage Free Cash Flow to Equity model assumes that these cash flows continue growing from this base rather than shrinking.

    Analyst projections used in the DCF see Agilent’s annual free cash flow rising into the mid to high $1b range and beyond over the coming decade before easing into a more modest second stage. That growth profile, combined with the discount rate used in the model, produces an estimated intrinsic value that is substantially below the current share price of $177.17. The completed acquisition of Proscia, which adds an AI enabled, recurring revenue software platform, may influence how dependable those future cash flows look to investors, but it does not prevent the model from landing below today’s market value. Find out what Agilent Technologies could be worth using our Discounted Cash Flow (DCF) estimate.

    The Agilent Technologies Narrative: What Would Justify Today's Price?

    Simply Wall St Narratives pick up where this valuation puzzle for Agilent Technologies leaves off. They spell out which paths for growth, profitability and earnings would need to play out for the stock to look meaningfully higher or lower than today’s price, and turn a single ratio or model output into a clear set of future conditions that you can watch over time to see whether that view still holds.

    One of the top community narratives on Agilent Technologies: roughly fairly valued

    "Growth in high recurring revenue activities such as Agilent CrossLab services and consumables continues to build a larger base of predictable, higher margin revenue..."

    Discover why this Narrative puts Agilent Technologies at roughly fairly valued.

    One more angle on Agilent Technologies that could change the picture

    Charts and cash flow models only tell part of the story, because the people setting priorities, taking risks and deciding how rewards are shared can tilt outcomes in ways the numbers alone will not show. See who runs Agilent Technologies and how they are paid.